NEW ORLEANS, April 17, 2018 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 11, 2018 to file lead plaintiff applications in a securities class action lawsuit against BRF S.A. (NYSE:BRFS), if they purchased the Company’s securities between April 4, 2013 and March 2, 2018, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
Get Help
BRF S.A. investors should visit us at https://www.claimsfiler.com/cases/view-brf-sa-securities-litigation or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
BRF S.A. and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
The alleged false and misleading statements and omissions include, but are not limited to, that: (i) BRF employees bribed regulators, among others, to unduly influence results of inspections to conceal unsanitary practices at the Company’s food processing plants; (ii) the discovery of the foregoing conduct would foreseeably subject the Company and its officers to heightened regulatory enforcement and/or prosecution; and (iii) as a result of the foregoing, BRF’s financial statements were materially false and misleading at all relevant times.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.


More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Anduril Eyes $60 Billion Valuation in New Funding Round to Expand Defense Manufacturing and Autonomous Fighter Jet Development
Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy
Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems
How Marco Pharma International Preserves German Homeopathic Traditions in America
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release
Valero Energy Expands Venezuelan Crude Imports as U.S. Sanctions Ease
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth 



